Publication Date:
1985-03-29
Description:
Concentrations of plasma homovanillic acid before treatment were highly correlated with global severity of illness in schizophrenic patients, both before and after treatment. In contrast, a fixed dose of haloperidol did not affect those concentrations. Thus, in patients with a diagnosis of schizophrenia, plasma homovanillic acid may reflect the severity of illness, but not be influenced by short-term pharmacological perturbations by neuroleptics.〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Davis, K L -- Davidson, M -- Mohs, R C -- Kendler, K S -- Davis, B M -- Johns, C A -- DeNigris, Y -- Horvath, T B -- MH37922/MH/NIMH NIH HHS/ -- New York, N.Y. -- Science. 1985 Mar 29;227(4694):1601-2.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/3975630" target="_blank"〉PubMed〈/a〉
Keywords:
Adult
;
Haloperidol/pharmacology
;
Homovanillic Acid/*blood
;
Humans
;
Male
;
Phenylacetates/*blood
;
Schizophrenia/*blood
Print ISSN:
0036-8075
Electronic ISSN:
1095-9203
Topics:
Biology
,
Chemistry and Pharmacology
,
Computer Science
,
Medicine
,
Natural Sciences in General
,
Physics
